Abstract:CD8+ T cells play a central role in anti-tumor immunity. Naive CD8+ T cells are active upon tumor antigen stimulation, and then differentiate into functional cells and migrate towards the tumor sites. Activated CD8+ T cells can directly destroy tumor cells by releasing perforin and granzymes and inducing apoptosis mediated by the death ligand/death receptor. They also secrete cytokines to regulate the immune system against tumor cells. Mitochondria are the central hub of metabolism and signaling, required for polarization, and migration of CD8+ T cells. Many studies have demonstrated that mitochondrial dysfunction impairs the anti-tumor activity of CD8+ T cells through various pathways. Mitochondrial energy metabolism maladjustment will cause a cellular energy crisis in CD8+ T cells. Abnormally high levels of mitochondrial reactive oxygen species will damage the integrity and architecture of biofilms of CD8+ T cells. Disordered mitochondrial dynamics will affect the mitochondrial number and localization within cells, further affecting the function of CD8+ T cells. Increased mitochondria-mediated intrinsic apoptosis will decrease the lifespan and quantity of CD8+ T cells. Excessively low mitochondrial membrane potential will cause the release of cytochrome c and apoptosis of CD8+ T cells, while excessively high will exacerbate oxidative stress. Dysregulation of mitochondrial Ca2+ signaling will affect various physiological pathways in CD8+ T cells. To some extent, mitochondrial abnormality in CD8+ T cells contributes to cancer development. So far, targeting mitochondrial energy metabolism, mitochondrial dynamics, mitochondria-mediated cell apoptosis, and other mitochondrial physiological processes to rebuild the anti-tumor function of CD8+ T cells has proved effective in some cancer models. Thus, mitochondria in CD8+ T cells may be a potential and powerful target for cancer treatment in the future.

Impact of mitochondrial dysfunction on the antitumor effects of immune cells

Research Progress on Mitochondria Regulating Tumor Immunity.

Targeting mitochondria: restoring the antitumor efficacy of exhausted T cells

Targeting mitochondrial damage: shining a new light on immunotherapy

Mitochondrial Immune Regulation and Anti-Tumor Immunotherapy Strategies Targeting Mitochondria

Mitochondria Dysfunction in CD8+ T Cells As an Important Contributing Factor for Cancer Development and a Potential Target for Cancer Treatment: a Review

Mitochondrial dysfunction: mechanisms and advances in therapy

The role of mitochondria in tumor metastasis and advances in mitochondria-targeted cancer therapy

Role of mitochondrial alterations in human cancer progression and cancer immunity

Mitochondria in tumor immune surveillance and tumor therapies targeting mitochondria

The Role of Mitochondrial Dynamics and Mitophagy in Carcinogenesis, Metastasis and Therapy.

Mitochondrial regulation in the tumor microenvironment: targeting mitochondria for immunotherapy

Targeting Cancer Cell Mitochondria As a Therapeutic Approach.

Impact of mitochondrial damage on tumor microenvironment and immune response: a comprehensive bibliometric analysis

Mitochondria Targeting as an Effective Strategy for Cancer Therapy

Decoding Mitochondria's Role in Immunity and Cancer Therapy

Mitochondria: a new intervention target for tumor invasion and metastasis

Mechanisms of Mitochondrial Dysfunction and its Influence on Cancer

Targeting Mitochondrial Quality Control of T Cells: Regulating the Immune Response in HCC

Targeting Mitochondrial Metabolic Reprogramming As a Potential Approach for Cancer Therapy

Advances in reprogramming of energy metabolism in tumor T cells